Brief: IPA Reports Results and Business Highlights for Q2 FY 2024
14/12/2023 14:42
Dec 14 (Reuters) - Immunoprecise Antibodies Ltd IPA.O :
* IPA REPORTS FINANCIAL RESULTS AND RECENT BUSINESS
HIGHLIGHTS FOR
SECOND QUARTER FISCAL YEAR 2024*
Source text for Eikon: ID:nBw7yKmdLa
Further company coverage: IPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai